These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 7106770)

  • 1. Genetic control of human apolipoprotein E polymorphism: comparison of one- and two-dimensional techniques of isoprotein analysis.
    Utermann G; Steinmetz A; Weber W
    Hum Genet; 1982; 60(4):344-51. PubMed ID: 7106770
    [No Abstract]   [Full Text] [Related]  

  • 2. Different mobility in SDS--polyacrylamide gel electrophoresis of apolipoprotein E from phenotypes apo E-N and Apo E-D.
    Utermann G; Weber W; Beisiegel U
    FEBS Lett; 1979 May; 101(1):21-6. PubMed ID: 221251
    [No Abstract]   [Full Text] [Related]  

  • 3. Human very low density lipoprotein apolipoprotein E isoprotein polymorphism is explained by genetic variation and posttranslational modification.
    Zannis VI; Breslow JL
    Biochemistry; 1981 Feb; 20(4):1033-41. PubMed ID: 6260135
    [No Abstract]   [Full Text] [Related]  

  • 4. Atypical familial dysbetalipoproteinemia associated with apolipoprotein phenotype E3/3.
    Havel RJ; Kotite L; Kane JP; Tun P; Bersot T
    J Clin Invest; 1983 Jul; 72(1):379-87. PubMed ID: 6860421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct phenotyping of human apolipoprotein E in plasma: application to population frequency distribution in Paris (France).
    Bailleul S; Couderc R; Landais V; Lefèvre G; Raichvarg D; Etienne J
    Hum Hered; 1993; 43(3):159-65. PubMed ID: 8330879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apolipoprotein E polymorphism and coronary artery disease.
    Menzel HJ; Kladetzky RG; Assmann G
    Arteriosclerosis; 1983; 3(4):310-5. PubMed ID: 6882285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymorphisms of apolipoprotein C-III in two cases with sialidase deficiency.
    Maeda H; Uzawa H; Nakamura N; Nakashima Y; Goto I
    Life Sci; 1981 Nov; 29(20):2065-9. PubMed ID: 7311733
    [No Abstract]   [Full Text] [Related]  

  • 8. Polymorphism of apolipoprotein E and occurrence of dysbetalipoproteinaemia in man.
    Utermann G; Hees M; Steinmetz A
    Nature; 1977 Oct; 269(5629):604-7. PubMed ID: 199847
    [No Abstract]   [Full Text] [Related]  

  • 9. A new isoform of apolipoprotein E--apo E-5--associated with hyperlipidemia and atherosclerosis.
    Yamamura T; Yamamoto A; Hiramori K; Nambu S
    Atherosclerosis; 1984 Feb; 50(2):159-72. PubMed ID: 6712769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetics of the apolipoprotein-E isoprotein system in man.
    Cumming AM; Robertson FW
    J Med Genet; 1982 Dec; 19(6):417-23. PubMed ID: 7154039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apolipoprotein EBethesda: a new variant of apolipoprotein E associated with type III hyperlipoproteinemia.
    Gregg RE; Ghiselli G; Brewer HB
    J Clin Endocrinol Metab; 1983 Nov; 57(5):969-74. PubMed ID: 6578216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unusual familial lipoprotein C-III associated with apolipoprotein C-III-O preponderance.
    Maeda H; Uzawa H; Kamei R
    Biochim Biophys Acta; 1981 Sep; 665(3):578-85. PubMed ID: 7295752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apolipoprotein E3-Leiden. A new variant of human apolipoprotein E associated with familial type III hyperlipoproteinemia.
    Havekes L; de Wit E; Leuven JG; Klasen E; Utermann G; Weber W; Beisiegel U
    Hum Genet; 1986 Jun; 73(2):157-63. PubMed ID: 3721502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apolipoprotein E Bethesda. Isolation and partial characterization of a variant of human apolipoprotein E isolated from very low density lipoproteins.
    Ghiselli G; Gregg RE; Brewer HB
    Biochim Biophys Acta; 1984 Jul; 794(2):333-9. PubMed ID: 6428460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apolipoprotein E polymorphism, serum lipids and occurrence of "double pre-betalipoproteinemia' (DPBL) in subjects from two different populations.
    Pagnan A; Zanetti G; Bonanome A; Biffanti S; Ehnholm C; Keso L; Lukka M
    Atherosclerosis; 1987 May; 65(1-2):23-8. PubMed ID: 3496894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a new structural variant of human apolipoprotein E, E2(Lys146 leads to Gln), in a type III hyperlipoproteinemic subject with the E3/2 phenotype.
    Rall SC; Weisgraber KH; Innerarity TL; Bersot TP; Mahley RW; Blum CB
    J Clin Invest; 1983 Oct; 72(4):1288-97. PubMed ID: 6313758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased Frequency of Apo E-ND phenotype and hyperapobeta-lipoproteinemia in normolipidemic subjects with xanthelasmas of the eyelids.
    Douste-Blazy P; Marcel YL; Cohen L; Giroux JM; Davignon J
    Ann Intern Med; 1982 Feb; 96(2):164-9. PubMed ID: 7059063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apolipoprotein E (role in lipoprotein metabolism and pathophysiology of hyperlipoproteinemia type III).
    Utermann G
    Ric Clin Lab; 1982; 12(1):23-30. PubMed ID: 6283616
    [No Abstract]   [Full Text] [Related]  

  • 19. Genetic polymorphism in human apolipoprotein E.
    Zannis VI
    Methods Enzymol; 1986; 128():823-51. PubMed ID: 3724530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apolipoprotein E phenotyping with a single gel method: application to the study of informative matings.
    Bouthillier D; Sing CF; Davignon J
    J Lipid Res; 1983 Aug; 24(8):1060-9. PubMed ID: 6631234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.